021-51111890
购物车（）
sales@molnova.cn
[Glu1]-Fibrinopeptide B
CAS No. 103213-49-6
[Glu1]-Fibrinopeptide B ( —— )
产品货号. M30562 CAS No. 103213-49-6
[Glu1]-Fibrinopeptide B is derived from fibrinopeptide B amino acid residues 1-14. Human fibrinopeptide B (hFpB), a thrombin-derived proteolytic cleavage product of the fibrinogen B beta-chain, to stimulate neutrophils (PMN), monocytes, and fibroblasts.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥5119 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称[Glu1]-Fibrinopeptide B
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述[Glu1]-Fibrinopeptide B is derived from fibrinopeptide B amino acid residues 1-14. Human fibrinopeptide B (hFpB), a thrombin-derived proteolytic cleavage product of the fibrinogen B beta-chain, to stimulate neutrophils (PMN), monocytes, and fibroblasts.
-
产品描述[Glu1]-Fibrinopeptide B is derived from fibrinopeptide B amino acid residues 1-14. Human fibrinopeptide B (hFpB), a thrombin-derived proteolytic cleavage product of the fibrinogen B beta-chain, to stimulate neutrophils (PMN), monocytes, and fibroblasts. (In Vitro):hFpB causes directed cell migration of PMN and fibroblasts that is optimal at approximately 10 nM. hFpB causes a rapid, dose-dependent increase in PMN cytoskeletal associated actin, but unlike fMLP, hFpB does not cause PMN aggregation, release of lysosomal enzymes (lysozyme and beta-glucuronidase), or the production of superoxide anion. These results suggest that hFpB may have a role in recruiting PMN and fibroblasts at sites of fibrin deposition and turnover. The capacity of hFpB to cause PMN chemotaxis without causing concurrent release of lysosomal enzymes or the production of superoxide anion is further evidence for the complexity of PMN responses to chemotactic agents.
-
体外实验hFpB causes directed cell migration of PMN and fibroblasts that is optimal at approximately 10 nM. hFpB causes a rapid, dose-dependent increase in PMN cytoskeletal associated actin, but unlike fMLP, hFpB does not cause PMN aggregation, release of lysosomal enzymes (lysozyme and beta-glucuronidase), or the production of superoxide anion. These results suggest that hFpB may have a role in recruiting PMN and fibroblasts at sites of fibrin deposition and turnover. The capacity of hFpB to cause PMN chemotaxis without causing concurrent release of lysosomal enzymes or the production of superoxide anion is further evidence for the complexity of PMN responses to chemotactic agents.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number103213-49-6
-
分子量1570.6
-
分子式C66H95N19O26
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称Sequence:Glu-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
Senior RM, et al. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest. 1986 Mar;77(3):1014-9.
产品手册
关联产品
-
DL-Methionine Methyl...
DL-蛋氨酸甲基氯化锍是一种天然产品，用于治疗消化性溃疡、结肠炎和胃炎。
-
2-MNG
2-MNG (2-Mercaptonicotinoyl glycine) acts as an inhibitor of melanin production, displaying an average IC50 of 49.5μM in normal human melanocytes. It binds to melanin precursors, preventing their incorporation into growing melanin which results in the inhibition of eumelanin and pheomelanin synthesis. Additionally, 2-MNG can be used in studies related to skin pigmentation disorders.
-
INDY
INDY 是 Dyrk1A 和 Dyrk1B 的 ATP 竞争性抑制剂，Dyrk1A ATP 口袋的 IC50 分别为 0.24 μM 和 0.23 μM，Ki 为 0.18 μM。
